Literature DB >> 22764767

The global breast cancer burden.

John R Benson1, Ismail Jatoi.   

Abstract

Breast cancer now represents the most common female malignancy in both the developing and developed world, and is the primary cause of death among women globally. Despite well-documented reductions in mortality from breast cancer during the past two decades, incidence rates continue to increase and do so more rapidly in countries that historically had low rates. This has emphasized the importance of survivorship issues and optimal management of disease chronicity. This article reviews current trends of incidence and mortality in both a western and global context, and considers pertinent changes in underlying etiological risk factors. The latter not only offer clues regarding changes in incidence patterns, but also provides rationale and guidance for strategies that could potentially reduce the burden of this disease. The relevance of lifestyle adjustments and screening interventions for primary and secondary prevention, respectively, are discussed with reference to different healthcare resource settings.

Entities:  

Mesh:

Year:  2012        PMID: 22764767     DOI: 10.2217/fon.12.61

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  96 in total

1.  A novel two-dimensional quantitative shear wave elastography for differentiating malignant from benign breast lesions.

Authors:  Li Tang; Hui-Xiong Xu; Xiao-Wan Bo; Bo-Ji Liu; Xiao-Long Li; Rong Wu; Dan-Dan Li; Lin Fang; Xiao-Hong Xu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.

Authors:  Suliman Y Alomar; Afrah Alkhuriji; Paul Trayhyrn; Abdulkarim Alhetheel; Abdullah Al-Jurayyan; Lamjed Mansour
Journal:  Immunogenetics       Date:  2016-09-15       Impact factor: 2.846

3.  The adaptation process of a teaching and research hospital to changing trends in modern breast surgery.

Authors:  Mustafa Gökhan Ünsal; Ahmet Cem Dural; Muhammet Ferhat Çelik; Cevher Akarsu; İrfan Başoğlu; M Ece Dilege; Selin Kapan; Halil Alış
Journal:  Ulus Cerrahi Derg       Date:  2014-10-20

4.  Aberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.

Authors:  Xi Gu; Jin-Qi Xue; Xi Zhu; Ming-Shi Ye; Wen-Hai Zhang
Journal:  Tumour Biol       Date:  2014-06-22

5.  Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.

Authors:  Xiaowei Zheng; Siying Chen; Qianting Yang; Jiangxia Cai; Weipeng Zhang; Haisheng You; Jianfeng Xing; Yalin Dong
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 6.  A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer.

Authors:  Rima Tawk; Vassiki Sanogo; Vakaramoko Diaby; Hong Xiao; Alberto J Montero
Journal:  Breast Cancer Res Treat       Date:  2015-04-19       Impact factor: 4.872

7.  Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.

Authors:  Guanqiao Li; Shiping Yang; Jia Yao; Zhenping Wang; Guangyu Yao; Mingfeng Liu; Changsheng Ye
Journal:  World J Surg Oncol       Date:  2016-08-05       Impact factor: 2.754

8.  Lack of association between cyclin-dependent kinase inhibitor 1B rs2066827 polymorphism and breast cancer susceptibility.

Authors:  Zhong-Ming Jia; Yan Liu; Shou-Yong Cui
Journal:  Tumour Biol       Date:  2014-02-13

9.  Ranking composite Cancer Burden Indices for geographic regions: point and interval estimates.

Authors:  Bin Huang; Elizabeth Pollock; Li Zhu; Jessica P Athens; Ron Gangnon; Eric J Feuer; Thomas C Tucker
Journal:  Cancer Causes Control       Date:  2018-01-25       Impact factor: 2.506

10.  Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population.

Authors:  Zhiping Deng; Hua Yang; Qiufang Liu; Zhouquan Wang; Tian Feng; Yongri Ouyang; Tianbo Jin; Hong Ren
Journal:  J Hum Genet       Date:  2016-09-08       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.